Pharmaceutical Predators

UPDATE: Note, this was written pre-cv19. All of the information stands, but the horror of their acts is amplified 1000 fold. I have documented the entire spectacle, saved reference links etc. Understand that I knew what was unfolding in the early days of cv19, based on my earlier research of these companies and their predatory behaviors. It wasn’t a surprise because the earlier rollout of swine flu was a blueprint for this project. But, at the time this ‘de-population project’ rolled out I did not anticipate the global scope of this nightmare. Nor could I imagine the zombie like behavior of their human mrna vaxx test subjects, including many of my own family members who are scattered across the country.

“Six years ago, John Ioannidis, a professor of epidemiology at the University of Ioannina School of Medicine in Greece, found that nearly half of published articles in scientific journals contained findings that were false, in the sense that independent researchers couldn’t replicate them. The problem is particularly widespread in medical research, where peer-reviewed articles in medical journals can be crucial in influencing multimillion- and sometimes multibillion-dollar spending decisions.

It would be surprising if conflicts of interest did not sometimes compromise editorial neutrality, and in the case of medical research, the sources of bias are obvious. Most medical journals receive half or more of their income from pharmaceutical company advertising and reprint orders, and dozens of others[journals] are owned by companies like Wolters Kluwer, a medical publisher that also provides marketing services to the pharmaceutical industry. Helen Epstein, author of “Flu Warning: Beware the Drug Companies”

“It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine.” Marcia Angell, MD, New York Review of Books, 2009